135 related articles for article (PubMed ID: 3291837)
1. A combination of levobunolol and dipivefrin for the treatment of glaucoma.
Allen RC; Robin AL; Long D; Novack GD; Lue JC; Kaplan G
Arch Ophthalmol; 1988 Jul; 106(7):904-7. PubMed ID: 3291837
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.
Walters TR; Maloney S; Slater D; Liss C; Wilson H; Hartenbaum D
Clin Ther; 1998; 20(6):1170-8. PubMed ID: 9916610
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of adding dipivefrin to a beta-blocker.
Geyer O; Rothkoff L; Lazar M
Ophthalmology; 1990 Oct; 97(10):1245-6. PubMed ID: 2243671
[No Abstract] [Full Text] [Related]
5. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
[TBL] [Abstract][Full Text] [Related]
6. Levobunolol compared with timolol: a four-year study.
Geyer O; Lazar M; Novack GD; Shen D; Eto CY
Br J Ophthalmol; 1988 Dec; 72(12):892-6. PubMed ID: 3067745
[TBL] [Abstract][Full Text] [Related]
7. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate.
Keates EU; Stone RA
Am J Ophthalmol; 1981 Feb; 91(2):243-8. PubMed ID: 7468740
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
Morrison JC; Robin AL
Ophthalmology; 1989 Jan; 96(1):3-7. PubMed ID: 2645550
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma treatment with once-daily levobunolol.
Wandel T; Charap AD; Lewis RA; Partamian L; Cobb S; Lue JC; Novack GD; Gaster R; Smith J; Duzman E
Am J Ophthalmol; 1986 Mar; 101(3):298-304. PubMed ID: 3513594
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
Seamone C; LeBlanc R; Saheb N; Novack G
Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
[TBL] [Abstract][Full Text] [Related]
13. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.
Silverstone D; Zimmerman T; Choplin N; Mundorf T; Rose A; Stoecker J; Kelley E; Lue J
Am J Ophthalmol; 1991 Jul; 112(1):56-60. PubMed ID: 1882923
[TBL] [Abstract][Full Text] [Related]
15. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic response interactions between timolol maleate and dipivefrin hydrochloride.
West RH; Gillies WE; Brooks AM
Aust N Z J Ophthalmol; 1987 May; 15(2):131-4. PubMed ID: 3620185
[TBL] [Abstract][Full Text] [Related]
17. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma.
Drake MV; Wilson MR; Harris D; Goodwin L
J Ocul Pharmacol; 1993; 9(2):91-5. PubMed ID: 8123096
[TBL] [Abstract][Full Text] [Related]
18. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
Berson FG; Cohen HB; Foerster RJ; Lass JH; Novack GD; Duzman E
Arch Ophthalmol; 1985 Mar; 103(3):379-82. PubMed ID: 3883972
[TBL] [Abstract][Full Text] [Related]
19. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
Stryz JR; Merté HJ
Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
[TBL] [Abstract][Full Text] [Related]
20. Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.
Boozman FW; Carriker R; Foerster R; Allen RC; Novack GD; Batoosingh AL
Arch Ophthalmol; 1988 May; 106(5):614-8. PubMed ID: 3282501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
